Form S-1 - General form for registration of securities under the Securities Act of 1933:
SEC Accession No. 0001140361-23-018529
Filing Date
2023-04-17
Accepted
2023-04-14 21:29:35
Documents
5

Document Format Files

Seq Description Document Type Size
1 S-1 ny20008758x1_s1.htm S-1 439013
2 EXHIBIT 5.1 ny20008758x1_ex5-1.htm EX-5.1 11651
3 EXHIBIT 23.1 ny20008758x1_ex23-1.htm EX-23.1 4353
4 EXHIBIT 23.2 ny20008758x1_ex23-2.htm EX-23.2 5630
5 FILING FEES TABLE ny20008758x1_ex107.htm EX-FILING FEES 26856
  Complete submission text file 0001140361-23-018529.txt   488799
Mailing Address 10531 4S COMMONS DRIVE SUITE 166-550 SAN DIEGO CA 92127
Business Address 1035 CAMBRIDGE STREET SUITE 18A CAMBRIDGE MA 02141 (212) 582-1199
Eterna Therapeutics Inc. (Filer) CIK: 0000748592 (see all company filings)

EIN.: 311103425 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-1 | Act: 33 | File No.: 333-271279 | Film No.: 23822683
SIC: 2834 Pharmaceutical Preparations